Thoracic Paravertebral Blocks Using a Combination of Ropivacaine and Dexmedetomidine

• Status: Unknown status
• Trial end date: 2019-03-30
• Target enrollment: 0
• Participant gender: All

Summary

The investigators designed a study to assess whether thoracic paravertebral blocks using a combination of ropivacaine and dexmedetomidine prolong nerve block duration.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: China Medical University, China
• Treatments: Dexmedetomidine; Ropivacaine

Criteria

Inclusion Criteria:

• Patients were included in the study if they were ethnic Chinese,

• American Society of Anesthesiologists (ASA) physical status I or II,

• candidates for general anesthesia undergoing thoracic surgery

Exclusion Criteria:

• Patients were excluded if they do not want to cooperate with the test,

• had a history of radial artery puncture or coronary artery bypass grafting,

• had acute vessel trauma,or had been diagnosed with Raynaud' disease,

• had suffered from mental or neurological disorders